Gordon Taylor相关文献与解析，生知库 | 链接生命科学的每一步

Moffat, Gordon Taylor; Hu, Zishuo Ian; Meric-Bernstam, Funda; Kong, Elisabeth Kathleen; Pavlick, Dean; Ross, Jeffrey S; Murugesan, Karthikeyan; Kwong, Lawrence; De Armas, Anaemy Danner; Korkut, Anil; Javle, Milind; Knox, Jennifer J

RAS

肿瘤

胆管癌

肿瘤免疫

发表日期：2024

文献求助收藏

Lower urinary tract symptoms in men: the TRIUMPH cluster RCT

男性下尿路症状：TRIUMPH 集群随机对照试验

期刊:Health Technology Assessment

影响因子:4

doi:10.3310/GVBC3182

Worthington, Jo; Frost, Jessica; Sanderson, Emily; Cochrane, Madeleine; Wheeler, Jessica; Cotterill, Nikki; MacNeill, Stephanie J; Noble, Sian; Avery, Miriam; Clarke, Samantha; Fader, Mandy; Hashim, Hashim; McGeagh, Lucy; Macaulay, Margaret; Rees, Jonathan; Robles, Luke; Taylor, Gordon; Taylor, Jodi; Thompson, Joanne; Lane, J Athene; Ridd, Matthew J; Drake, Marcus J

发表日期：2024

文献求助收藏

Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study

跨专业诊疗模式对胰腺癌预后的影响：一项回顾性队列研究

期刊:Current Oncology

影响因子:3.4

doi:10.3390/curroncol31050194

Moffat, Gordon Taylor; Coyne, Zachary; Albaba, Hamzeh; Aung, Kyaw Lwin; Dodd, Anna; Espin-Garcia, Osvaldo; Moura, Shari; Gallinger, Steven; Kim, John; Fraser, Adriana; Hutchinson, Shawn; Moulton, Carol-Anne; Wei, Alice; McGilvray, Ian; Dhani, Neesha; Jang, Raymond; Elimova, Elena; Moore, Malcolm; Prince, Rebecca; Knox, Jennifer

Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial

一项针对男性下尿路症状的初级保健干预措施的成本效益分析：TRIUMPH 整群随机对照试验

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2023-075704

Cochrane, Madeleine; Drake, Marcus J; Worthington, Jo; Frost, Jessica; Cotterill, Nikki; Fader, Mandy; McGeagh, Lucy; Hashim, Hashim; Lane, Athene; Macaulay, Margaret; MacNeill, Stephanie; Rees, Jonathan; Ridd, Matthew J; Robles, Luke A; Sanderson, Emily; Taylor, Gordon; Taylor, Jodi; Noble, Sian

发表日期：2024

文献求助收藏

Treatment of lower urinary tract symptoms in men in primary care using a conservative intervention: cluster randomised controlled trial

在基层医疗机构中，采用保守干预措施治疗男性下尿路症状：一项整群随机对照试验

期刊:Bmj-British Medical Journal

影响因子:42.7

doi:10.1136/bmj-2023-075219

Drake, Marcus J; Worthington, Jo; Frost, Jessica; Sanderson, Emily; Cochrane, Madeleine; Cotterill, Nikki; Fader, Mandy; McGeagh, Lucy; Hashim, Hashim; Macaulay, Margaret; Rees, Jonathan; Robles, Luke A; Taylor, Gordon; Taylor, Jodi; Ridd, Matthew J; MacNeill, Stephanie J; Noble, Sian; Lane, J Athene

发表日期：2023

文献求助收藏

The association between perioperative frailty and ability to complete a web-based geriatric assessment among older adults with cancer

围手术期虚弱与老年癌症患者完成基于网络的老年评估能力之间的关联

期刊:Ejso

影响因子:2.9

doi:10.1016/j.ejso.2022.11.011

Cuadra, Andrea; Tin, Amy L; Moffat, Gordon Taylor; Alexander, Koshy; Downey, Robert J; Korc-Grodzicki, Beatriz; Vickers, Andrew J; Shahrokni, Armin

A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic

一项关于在 COVID-19 大流行期间延长度伐利尤单抗给药治疗 III 期不可切除非小细胞肺癌 (NSCLC) 患者的疗效和毒性结果的研究

期刊:Cancer Treatment and Research Communications

影响因子:2.4

doi:10.1016/j.ctarc.2022.100678

Hanna, Lilian; Moffat, Gordon Taylor; Hopman, Wilma; Gaudreau, Pierre-Olivier; Fung, Andrea S

An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic

在 COVID-19 大流行期间，对晚期非小细胞肺癌患者延长帕博利珠单抗给药方案的评估

期刊:Immunotherapy

影响因子:2.3

doi:10.2217/imt-2022-0257

Moffat, Gordon Taylor; Hanna, Lilian; Hopman, Wilma; Fung, Andrea S; Gaudreau, Pierre-Olivier

Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study

肠道吸附剂 Silicol®gel 对成人肠易激综合征亚型（IBS-D 或混合型）的疗效：一项观察性开放标签研究

期刊:Gastroenterology Research and Practice

影响因子:1.4

doi:10.1155/2023/3432763

Crawford, Gordon; Taylor, Rory; Young, David; Hatton, Chris G

肠易激综合征

发表日期：2023

文献求助收藏

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

基于人类的多基因特征谱能够实现代谢疾病的定量药物再利用。

期刊:Elife

影响因子:6.4

doi:10.7554/eLife.68832

Timmons, James A; Anighoro, Andrew; Brogan, Robert J; Stahl, Jack; Wahlestedt, Claes; Farquhar, David Gordon; Taylor-King, Jake; Volmar, Claude-Henry; Kraus, William E; Phillips, Stuart M

代谢

发表日期：2022

文献求助收藏

KRAS Allelic Variants in Biliary Tract Cancers

胆道癌中的KRAS等位基因变异

Lower urinary tract symptoms in men: the TRIUMPH cluster RCT

男性下尿路症状：TRIUMPH 集群随机对照试验

Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study

跨专业诊疗模式对胰腺癌预后的影响：一项回顾性队列研究

Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial

一项针对男性下尿路症状的初级保健干预措施的成本效益分析：TRIUMPH 整群随机对照试验

Treatment of lower urinary tract symptoms in men in primary care using a conservative intervention: cluster randomised controlled trial

在基层医疗机构中，采用保守干预措施治疗男性下尿路症状：一项整群随机对照试验

The association between perioperative frailty and ability to complete a web-based geriatric assessment among older adults with cancer

围手术期虚弱与老年癌症患者完成基于网络的老年评估能力之间的关联

A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic

一项关于在 COVID-19 大流行期间延长度伐利尤单抗给药治疗 III 期不可切除非小细胞肺癌 (NSCLC) 患者的疗效和毒性结果的研究

An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic

在 COVID-19 大流行期间，对晚期非小细胞肺癌患者延长帕博利珠单抗给药方案的评估

Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study

肠道吸附剂 Silicol®gel 对成人肠易激综合征亚型（IBS-D 或混合型）的疗效：一项观察性开放标签研究

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

基于人类的多基因特征谱能够实现代谢疾病的定量药物再利用。